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Hyperuricemia is a biochemical abnormality and it affects the quality of life. Many medicinal substances are used in 
lowering the uric acid. The study designed to find hypouricemic effects ofultrahigh dilutions, the gum of Calophyllum 
inophyllum, Acid benzoicum in oxonate of potassium induced hyperuricemic wistar albinomodel. 
The experiment consist of 11 groups of albino rats. All the groups were treated with oxonate of potassium except normal 
control. Healthy group of animals received only distilled water, hyperuricemic control group were given alcohol mixed in 
distilled water. A standard allopathic medical substance Allopurinol and Acid benzoicum ultra high dilutions were given in 
time dependent manner (single dose/day) in different experimental groups. Blood samples were collected by rat tail vein 
bleeding. The uric acid and creatinine levels of serum were analyzed by using standard measuring kits. The Student's t-test 
was used for statistical analysis of difference between the groups p ≤ 0.05 was reflected significant.  
Oral intake of Acid benzoicum ultrahigh dilutions reduceduric acid levels of hyperuricemic wistar albino rats in time 
dependent mode. At 3rd day and 7th day administration of Acid benzoicum ultrahigh dilutions decreased the level of uric acid 
more ominously as compared to one day administration. However, allopurinol a standard allopathic drug normalized the uric 
acid level in all experimental groups.  
The current work showed significant hypouricemic effects of Acid benzoicum ultrahigh dilutions in hyperuricemic wistar 
albino model. However, clear conclusion of hypouricemic activity of Acid benzoicum needed repetition of experimental work. 
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Hyperuricemia is a common biochemical abnormality 
globally with raised level of uric acid (UA) up to 6.8 
mg/dL1. It may be caused by increased production or 
lesser excretion of uric acid. Worldwide prevalence of 
hyperurecemia is 20-25%. Allopurinol is the only 
available non-steroidal drug for the treatment of 
Hyperurecemia (Gout) and the drug has fewer side 
effects such as allergic reactions which limit their use 
in patients. Therefore it is the need to introduce new 
hypouricemic agents2,3. The old literature of 
homeopathy showed that Acid benzoicum (gum of 
Calophyllum inophyllum) is an organopathic remedy 
for amelioration of gouty complaints due to 
hyperuricemia. It excretes the uric acid crystals 
through urine4. The primary objective of experiment 
was to find hypouricemic effects of Acid benzoicum 
ultrahigh dilutions on uric acid in potassium oxonate 
induced hyperuricemia Wister albino rat model.  
The research hypothesis is evaluated for application 
of the 3R’s (replacement reduction and refinement) of 
laboratory animals and procedures by Pharmacy 
Research Ethics committee (PREC), The Islamia 
University Bahawalpur prior to the start of 
experimental work (approval no. Ref No. 41-
2016/PREC dated 23-08-2016.). After application of 
3R’s, rat model was selected. The whole manuscript 
complied to the ARRIVE guidelines5.  
The Wistar albino rats (150-250 g) were placed in 
polycarbonate cages (47 × 34 × 18 in2) and were 
alienated into 11 different groups and each group 
consisted of 4 animals. Sample size was calculated 
through resource equation method and was sufficient 
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for statistical analysis6. The animals were treated and 
assessed in the order given in Fig. 1. Oxonate of 
Potassium (250 mg/kg) was used to induce the 
hyperuricemia in rats, as described previously7. All the 
medicines including allopurinol, ultra high dilutions of 
homeopathic medicines, and succussed alcohol were 
given orally once daily at 10 am - 11 am. Nine groups 
were orally administered with allopurinol 10 mg/kg, 
Acid benzoicum 1 min, Acid benzoicum 30 c for 1, 3 
and 7 days respectively. Two groups, normal control 
and hyperuricemic control were given distilled water 
and succussed alcohol 70% (vehicle of used 
homeopathic medicines as per company mentioned) 
respectively. Homeopathic ultrahigh dilutions and 70% 
succussed alcohol were mixed (2 drops) in 1 cc 
distilled water for oral administration. After one hour 
administration of medicine on day 1st, 3rd and 7th, blood 
samples were collected from rats by tail vein bleeding. 
Blood was centrifuged at 3000 rpm for 5 min to get 
serum. Serum was preserved at -20ºC until analyzed1. 
The level of uric acid and creatinine levels in serum 
were analyzed by using Microlab 300. Uric acid 
liquicolor kit and Creatinine liquicolor kit (human 
diagnostic worldwide) were used respectively. Results 
obtained by this activity were analyzed by SPSS 
software. The Data was expressed in the form of mean 
± standard error of mean (SEM). The p ≤ 0.05 (Two 
tailed values) was considered significant.  
The baseline characteristics of different 
experimental groups were mentioned in Table 1. Fig. 
1 clearly demonstrates the statistically significant 
antihyperuriemic effects of Acid benzoicum 30 c and 
1 min in time dependent manner. There were no 
adverse event (immobility, loss of weight, an inability 
to eat or drink or death of animals) observed during 
course of study. Serum creatinine levels were also 
reduced in time dependent manner. (Table 2)  
The present study evaluated the effects of Acid 
benzoicum 30 c and Acid benzoicum 1 min 
hyperuricemia in potassium oxonate induced 
hyperuricemic model of rats. A rapid increase in levels 
of uric acid in serum in all the groups compared to 
normal control group indicating that the hyperuricemia 
rat model was effectively established. This finding 
matched to the previous studies reporting 
hyperuricemia induced by potassium oxonate intra 
peritoneal in rats and mice1,7-9. Hyperuricemia triggered 
when there are disturbances in uric acid regulating 
pathways. Potassium oxonate causes hyperuricemia by 
inhibition of uricase or by blocking of an electrogenic 
Table 1 Baseline Characteristics of different groups 
Baseline Characteristics 
Baseline data of different groups. 
Normal 
control 
Hyperuricemic 
control 
Standard control 
(1, 3, 7 day study groups) 
Acid benzoicum 30c 
(1, 3, 7 day study groups) 
Acid benzoicum 1M 
(1, 3, 7 day study groups) 
Body weight (g) 
(Mean ±S.E.M) 206 ±4 203 ±7 206 ±4 201 ±3 201 ±2 
Serum uric acid 
(Mean ± S.E.M) 1.3±0.07 1.5±0.06 1.4±0.07 1.4±0.08 1.4±0.05 
 
 
Fig. 1 — Effects of Acid benzoicum 30 c, 1M and allopurinol on 
serum UA levels on day 1, 3, 7 in rats 
Table 2 Effects of Creatinine level in wistar albino rats administered with Acid benzoicum 
 
Treatment 
 
Dosage 
Serum creatinine level (mg/dL) 
1 day 
study 
3day 
study 
7 day study 
Normal control  0.3±.07 0.2±.06 0.2±.05 
Negative control  2.3± 0.6## 2.4±0.21## 2.7±1.4## 
Standard control  10 mg/kg 0.4±.07** 0.3±.02** 0.2±0.1** 
Acid benzoicum 30C 5 drops in 10cc distilled water 0.5±0.06*## 0.3±0.08** 0.3±0.2** 
Acid benzoicum 1M 5 drops in 10cc distilled water 0.6±0.05*## 0.4±0.13** 0.4±0.13** 
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urate transporter activity in renal proximal tubule that 
controls serum UA levels10-12. Antihperuricemic drugs 
reduced hyperuricemia by inhibiting xanthine oxidase 
and action on renal or extra-renal urate transporters. In 
the present study, orally administered allopurinol  
(10 mg/kg) significantly decreased potassium oxonate 
induced hyperuricemia in rats. It has action on a urate 
transporter and Cl/urate transporter and inhibit xanthine 
oxidase8. Results matched to the several studies 
presented the reduction of hyperuricemia with 
allopurinol at same dosage1,13,14. According to previous 
research, potassium oxonate induced hyperuricemia in 
rats may be due to either blocking of UAT activity or 
inhibition of uricase activity. One day study depicts the 
antihyperuicemic potential of allopurinol, Acid 
benzoicum 30 c and 1 min in potassium oxonate 
induced rat model that received medicines after one 
hour of intra peritoneal injection of potassium oxonate. 
The rats of 3 day and 7 day study groups received 
homeopathic medicines as well as allopurinol for 
consecutive 2 or 6 days respectively and then received 
single potassium oxonate intra peritoneal injection 
before final dose of medicines. Potassium oxonate is a 
hyperuricemia inducing agent, but when rats previously 
treated with allopurinol, Acid benzoicum 30 c and  
1 min received potassium oxonate, serum uric acid 
levels remained normal in all the groups. Hahnemann, 
founder of homeopathy, described in aphorism 43 that 
when two similar diseases meet together in an 
organism, it resulted in cure15. During one day study, 
Acid benzoicum administration reduced serum uric acid 
level. However, single dose of homeopathic medicine 
administration can’t turn increased serum UA to 
normal levels. A homeopathic medicine gently 
annihilates similar acute disease with slight 
homeopathic aggravation (aphorism 154, 155)16. The 
initial elevated serum UA levels may be due to 
homeopathic aggravation.  
Homeopathic medicines could act as prophylactic 
when administered to healthy individuals having risk of 
disease. Arsenicum album and Veratrum album are the 
two well-known homeopathic medicines used as a 
prophylactic of cholera. It might be possible that 
homeopathic medicines administered in 3 day or 7 day 
study groups produce prophylactic effect in rats that 
inhibit the action of potassium oxonate in those rats. 
Moreover, a homeopathic drug proving (HDP) is the 
application of a substance in nontoxic dilutions to 
healthy individuals. The tested material causes mental, 
physical or psychological symptoms that can be 
reversed17. The specific effects of homeopathic 
medicines are of non-molecular origin, yet provide 
powerful clinically effective biological activities18. The 
potencies selected in current study were medium (30 c) 
and higher (1 min). Both potencies showed similar 
hypouricemic potential in rats. It has been assumed that 
highly diluted substances transfer biological activity to 
cells by electromagnetic fields19. In conclusion, the 
current study indicated antihyperuricemic potential of 
Acid benzoicum 30 c and 1 min in oxonate of 
potassium induced hyperuricemia model of wistar 
albino rats model in time dependent manner.  
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